Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


  1. Published

    Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts

    Agrawal, A., Kruse, L. S., Vangsted, Annette Juul, Gartland, A. & Jørgensen, Niklas Rye, 2020, In: Cells. 9, 11

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14)

    Bahlis, N. J., Baz, R., Harrison, S. J., Quach, H., Ho, S. J., Vangsted, Annette Juul, Plesner, T., Moreau, P., Gibbs, S. D., Coppola, S., Yang, X., Al Masud, A., Ross, J. A., Bueno, O. & Kaufman, J. L., 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39, 32, p. 3602-3612

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation

    Bertelsen, L. D., Børty Nielsen, L., Christensen, H. S., Bøgsted, M., Gregersen, H., Pedersen, R. S., Klostergaard, A., Schnack, B. I., Pedersen, P. T., Abildgaard, N., Hermansen, E., Vangsted, Annette Juul & Severinsen, M. T., 2023, In: European Journal of Haematology. 110, 3, p. 289-295 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

    Blimark, C. H., Vangsted, Annette Juul, Klausen, T. W., Gregersen, H., Szabo, A. G., Hermansen, E., Wålinder, G., Knut-Bojanowska, D., Zang, C., Turesson, I. & the Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG), T. R. E. G. W. T. N. M. S. G. (., 2022, In: European Journal of Haematology. 108, 2, p. 99-108 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR⿻/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma

    Brimnes, M. K., Vangsted, Annette Juul, Knudsen, L. M., Gimsing, P., Gang, Uffe Jakob Ortved, Johnsen, H. & Svane, Inge Marie, 2010, In: Scandinavian Journal of Immunology. 72, 6, p. 540-7

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

    Campa, D., Martino, A., Macauda, A., Dudziński, M., Suska, A., Druzd-Sitek, A., Raab, M-S., Moreno, V., Huhn, S., Butrym, A., Sainz, J., Szombath, G., Rymko, M., Marques, H., Lesueur, F., Vangsted, A. J., Vogel, U., Kruszewski, M., Subocz, E., Buda, G. & 27 others, Iskierka-Jażdżewska, E., Ríos, R., Merz, M., Schöttker, B., Mazur, G., Perrial, E., Martinez-Lopez, J., Butterbach, K., García Sanz, R., Goldschmidt, H., Brenner, H., Jamroziak, K., Reis, R. M., Kadar, K., Dumontet, C., Wątek, M., Haastrup, E. K., Helbig, G., Jurczyszyn, A., Jerez, A., Varkonyi, J., Barington, T., Grzasko, N., Zaucha, J. M., Andersen, V., Zawirska, D. & Canzian, F., Jul 2019, In: Leukemia and Lymphoma. 60, 7, p. 1803-1811 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

    Campa, D., Martino, A., Varkonyi, J., Lesueur, F., Jamroziak, K., Landi, S., Jurczyszyn, A., Marques, H., Andersen, V., Jurado, M., Brenner, H., Petrini, M., Vogel, U., García-Sanz, R., Buda, G., Gemignani, F., Ríos, R., Vangsted, A. J., Dumontet, C., Martínez-López, J. & 16 others, Moreno, M. J., Stępień, A., Wątek, M., Moreno, V., Dieffenbach, A. K., Rossi, A. M., Butterbach, K., Jacobsen, S. E. H., Goldschmidt, H., Sainz, J., Hillengass, J., Orciuolo, E., Dudziński, M., Weinhold, N., Reis, R. M. & Canzian, F., 1 Mar 2015, In: International Journal of Cancer. 136, 5, p. E351-8

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    A polygenic risk score for multiple myeloma risk prediction

    Canzian, F., Piredda, C., Macauda, A., Zawirska, D., Andersen, N. F., Nagler, A., Zaucha, J. M., Mazur, G., Dumontet, C., Wątek, M., Jamroziak, K., Sainz, J., Várkonyi, J., Butrym, A., Beider, K., Abildgaard, N., Lesueur, F., Dudziński, M., Vangsted, A. J., Pelosini, M. & 20 others, Subocz, E., Petrini, M., Buda, G., Raźny, M., Gemignani, F., Marques, H., Orciuolo, E., Kadar, K., Jurczyszyn, A., Druzd-Sitek, A., Vogel, U., Andersen, V., Reis, R. M., Suska, A., Avet-Loiseau, H., Kruszewski, M., Tomczak, W., Rymko, M., Minvielle, S. & Campa, D., 2022, In: European Journal of Human Genetics. 30, 4, p. 474-479 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    Clavero, E., Sanchez-Maldonado, J. M., Macauda, A., Ter Horst, R., Sampaio-Marques, B., Jurczyszyn, A., Clay-Gilmour, A., Stein, A., Hildebrandt, M. A. T., Weinhold, N., Buda, G., García-Sanz, R., Tomczak, W., Vogel, U., Jerez, A., Zawirska, D., Wątek, M., Hofmann, J. N., Landi, S., Spinelli, J. J. & 52 others, Butrym, A., Kumar, A., Martínez-López, J., Galimberti, S., Sarasquete, M. E., Subocz, E., Iskierka-Jażdżewska, E., Giles, G. G., Rybicka-Ramos, M., Kruszewski, M., Abildgaard, N., Verdejo, F. G., Sánchez Rovira, P., da Silva Filho, M. I., Kadar, K., Razny, M., Cozen, W., Pelosini, M., Jurado, M., Bhatti, P., Dudzinski, M., Druzd-Sitek, A., Orciuolo, E., Li, Y., Norman, A. D., Zaucha, J. M., Reis, R. M., Markiewicz, M., Rodríguez Sevilla, J. J., Andersen, V., Jamroziak, K., Hemminki, K., Berndt, S. I., Rajkumar, V., Mazur, G., Kumar, S. K., Ludovico, P., Nagler, A., Chanock, S. J., Dumontet, C., Machiela, M. J., Varkonyi, J., Camp, N. J., Ziv, E., Vangsted, Annette Juul, Brown, E. E., Campa, D., Vachon, C. M., Netea, M. G., Canzian, F., Försti, A. & Sainz, J., 2023, In: International Journal of Molecular Sciences. 24, 10, 20 p., 8500.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis

    Coleman, E. A., Lee, J. Y., Erickson, S. W., Goodwin, J. A., Sanathkumar, N., Raj, V. R., Zhou, D., McKelvey, K. D., Apewokin, S., Stephens, O., Enderlin, C. A., Vangsted, Annette Juul, Reed, P. J. & Anaissie, E. J., Mar 2015, In: Supportive Care in Cancer. 23, 3, p. 841-9 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    Dicanio, M., Giaccherini, M., Clay-Gilmour, A., Macauda, A., Sainz, J., Machiela, M. J., Rybicka-Ramos, M., Norman, A. D., Tyczyńska, A., Chanock, S. J., Barington, T., Kumar, S. K., Bhatti, P., Cozen, W., Brown, E. E., Suska, A., Haastrup, E. K., Orlowski, R. Z., Dudziński, M., Garcia-Sanz, R. & 42 others, Kruszewski, M., Martinez-Lopez, J., Beider, K., Iskierka-Jazdzewska, E., Pelosini, M., Berndt, S. I., Raźny, M., Jamroziak, K., Rajkumar, S. V., Jurczyszyn, A., Vangsted, Annette Juul, Collado, P. G., Vogel, U., Hofmann, J. N., Petrini, M., Butrym, A., Slager, S. L., Ziv, E., Subocz, E., Giles, G. G., Andersen, N. F., Mazur, G., Watek, M., Lesueur, F., Hildebrandt, M. A. T., Zawirska, D., Ebbesen, L. H., Marques, H., Gemignani, F., Dumontet, C., Várkonyi, J., Buda, G., Nagler, A., Druzd-Sitek, A., Wu, X., Kadar, K., Camp, N. J., Grzasko, N., Waller, R. G., Vachon, C., Canzian, F. & Campa, D., 2023, In: International Journal of Cancer. 152, 2, p. 239-248 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3

    Erickson, S. W., Stephens, O. W., Chavan, S. S., Epstein, J., Barlogie, B., Heuck, C. J. & Vangsted, Annette Juul, Sep 2016, In: British Journal of Haematology. 174, 6, p. 991-993 3 p.

    Research output: Contribution to journalComment/debateResearch

  13. Published

    The Danish National Multiple Myeloma Registry

    Gimsing, P., Holmström, M. O., Klausen, T. W., Andersen, N. F., Gregersen, H., Pedersen, R. S., Plesner, T., Pedersen, P. T., Frederiksen, M., Frølund, U. C., Helleberg, C., Vangsted, Annette Juul, Brown, Peter de Nully & Abildgaard, N., 25 Oct 2016, In: Clinical Epidemiology. 8, p. 583-587 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group

    Gregersen, H., Peceliunas, V., Remes, K., Schjesvold, F., Abildgaard, N., Nahi, H., Andersen, N. F., Vangsted, A. J., Klausen, T. W., Helleberg, C., Carlson, K., Frølund, U. C., Axelsson, P., Stromberg, O., Blimark, C. H., Crafoord, J., Tsykunova, G., Eshoj, H. R., Waage, A., Hansson, M. & 1 others, Gulbrandsen, N., 2022, In: European Journal of Haematology. 108, 1, p. 34-44 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

    Gregersen, H., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Nielsen, L. K., Andersen, Christen Bertel L, Klausen, T. W., Vangsted, Annette Juul & Abildgaard, N., 2018, In: Experimental Hematology & Oncology. 7, 1, 18.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study

    Gregersen, H., Vangsted, Annette Juul, Abildgaard, N., Andersen, N. F., Pedersen, R. S., Frølund, U. C., Helleberg, C., Broch, B., Pedersen, P. T., Gimsing, P. & Klausen, T. W., Jun 2017, In: Cancer Medicine. 6, 7, p. 1807-1816 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    Potential value of pre-planned imaging of bone disease in multiple myeloma

    Nordic Myeloma Study Group, N. M. S. G., 2023, In: Blood Cancer Journal. 13, 1, 5 p., 105.

    Research output: Contribution to journalEditorialResearchpeer-review

  18. Published

    Lenalidomide Maintenance in Multiple Myeloma: A Retrospective, Nationwide, Real-World Study

    Harsløf, Mads, Chanchiri, I., Silkjær, T., Frølund, U. C., Teodorescu, E. M., Nielsen, K. B., Nielsen, P. I., Pedersen, P. T., Iversen, K. F., Grønbæk, Kirsten, Vangsted, Annette Juul, Thorsteinsdottir, S. & Szabo, A. G., 2023, In: Blood. 142, Supplement 1, p. 1979 1 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014

    Helm-Petersen, S., Sørrig, R., Klausen, T. W., Preiss, B., Frølund, U. C., Helleberg, C., Breinholt, M., Andersen, M. K., Abildgaard, N., Gimsing, P. & Vangsted, Annette Juul, 2018, In: Leukemia. 32, p. 2054-2057

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation

    Hermansen, N. E. U., Borup, R., Andersen, M. K., Vangsted, Annette Juul, Clausen, T. N., Kristensen, D. L., Nielsen, Finn Cilius & Gimsing, P., Jun 2016, In: International Journal of Laboratory Hematology. 38, 3, p. 298-307 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

    Holmström, M. O., Gimsing, P., Abildgaard, N., Andersen, N. F., Helleberg, C., Clausen, N. A. T., Klausen, T. W., Frederiksen, M., Kristensen, D. L., Larsen, H., Pedersen, P. T., Andersen, K. T., Pedersen, R. S., Jensen, B. A., Gregersen, H. & Vangsted, Annette Juul, Apr 2015, In: American Journal of Hematology. 90, 4, p. E73-E74

    Research output: Contribution to journalComment/debateResearchpeer-review

  22. Published

    Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients

    Højholt, K. L., Gregersen, H., Szabo, A. G., Klausen, T. W., Levring, M. B., Preiss, B., Helleberg, C., Breinholt, M. F., Hermansen, E., Gjerdrum, Lise Mette Rahbek, Bønløkke, S. T., Nielsen, K., Kjeldsen, E., Iversen, K. F., Teodorescu, E. M., Kurt, E., Strandholdt, C., Andersen, M. K. & Vangsted, Annette Juul, 2021, In: Hematological Oncology. 39, 4, p. 521-528

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Interferon-alpha in the treatment of multiple myeloma

    Khoo, T. L., Joshua, D., Gibson, J. & Vangsted, Annette Juul, 1 Jan 2011, In: Current Drug Targets. 12, 3, p. 437-446 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

    Klausen, T. W., Gregersen, H., Abildgaard, N., Andersen, N. F., Frølund, U. C., Gimsing, P., Helleberg, C. & Vangsted, Annette Juul, Feb 2019, In: Leukemia. 33, 2, p. 546-549 4 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  25. Published

    Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma

    Lund, J., Gruber, A., Lauri, B., Duru, A. D., Blimark, C., Swedin, A., Hansson, M., Forsberg, K., Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, Annette Juul, Frølund, U., Holmberg, E., Gahrton, G., Alici, E., Hardling, M., Mellqvist, U. & Nahi, H., 2018, In: Cancer Medicine. 7, 6, p. 2256-2268 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 Next

ID: 9762536